ストックスクリーナーアプリを入手
8.17
3.77%
-0.32
前日終値:
$8.49
開ける：
$8.52
24時間の取引高:
468.18K
Relative Volume:
0.54
時価総額：
$965.27M
収益：
$247.00M
当期純損益:
$-249.00M
株価収益率:
-2.644
EPS:
-3.09
ネットキャッシュフロー:
$-267.00M
1週間 パフォーマンス:
-8.61%
1か月 パフォーマンス:
-17.31%
6か月 パフォーマンス:
-46.98%
1年 パフォーマンス:
-56.73%
1日の値動き範囲:
$8.12
$8.57
1週間の範囲:
$8.02
$9.19
52週間の値動き範囲:
$8.02
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
名前
Arcus Biosciences Inc
セクター
電話
(510) 694-6200
住所
3928 POINT EDEN WAY, HAYWARD, CA
RCUS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
8.17 | 965.27M | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-26 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | 開始されました | H.C. Wainwright | Neutral |
| 2024-10-08 | 開始されました | Wells Fargo | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Neutral |
| 2022-10-11 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-11-23 | 開始されました | Evercore ISI | Outperform |
| 2020-04-03 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-09-27 | 開始されました | Mizuho | Buy |
| 2019-05-24 | 再開されました | Citigroup | Buy |
| 2018-10-09 | 開始されました | Wedbush | Outperform |
| 2018-04-09 | 開始されました | Citigroup | Buy |
| 2018-04-09 | 開始されました | Goldman | Neutral |
| 2018-04-09 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Arcus Biosciences Inc (RCUS) 最新ニュース
Arcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance
Arcus Biosciences Announces New Employment Inducement Grants - Bluefield Daily Telegraph
Cancer Therapy Pioneer Arcus Biosciences Accelerates Growth with Key Team Expansion - StockTitan
RCUS stock touches 52-week low at $8.97 amid market challenges - Investing.com Australia
RCUS stock touches 52-week low at $8.97 amid market challenges By Investing.com - Investing.com South Africa
Arcus Biosciences, Inc. (RCUS): Among Top Insider Purchases Last Month - Insider Monkey
RCUS FY2025 EPS Estimate Raised by Cantor Fitzgerald - Defense World
Arcus Biosciences at Barclays Conference: Strategic Pipeline Insights By Investing.com - Investing.com Canada
Top 10 Insider Purchases Last Month - Insider Monkey
(RCUS) Investment Analysis - Stock Traders Daily
Arcus Biosciences at Leerink’s Global Healthcare Conference: Strategic Advancements By Investing.com - Investing.com Canada
RCUS stock touches 52-week low at $9.42 amid market challenges - Investing.com Australia
Terry Rosen Increases Stake in Arcus Biosciences Inc (RCUS) with Recent Share Purchase - GuruFocus.com
Little Excitement Around Arcus Biosciences, Inc.'s (NYSE:RCUS) Revenues As Shares Take 26% Pounding - Simply Wall St
Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares - Yahoo Canada Finance
Learn to Evaluate (RCUS) using the Charts - Stock Traders Daily
Arcus Biosciences (NYSE:RCUS) Upgraded at HC Wainwright - Defense World
Wedbush Forecasts Arcus Biosciences’ Q1 Earnings (NYSE:RCUS) - Defense World
Arcus Biosciences director Yasunori Kaneko buys $201,200 in shares By Investing.com - Investing.com South Africa
Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance UK
What is Leerink Partnrs’ Forecast for RCUS Q1 Earnings? - Defense World
Arcus Biosciences CEO Terry J. Rosen buys $201,465 in common stock - Investing.com Australia
Arcus Biosciences CEO Terry J. Rosen buys $201,465 in common stock By Investing.com - Investing.com South Africa
Arcus Biosciences director Yasunori Kaneko buys $201,200 in shares - Investing.com India
Arcus Biosciences Executives Increase Their Holdings - TradingView
RCUS stock touches 52-week low at $9.88 amid market challenges - Investing.com
RCUS stock touches 52-week low at $9.88 amid market challenges By Investing.com - Investing.com South Africa
Arcus Biosciences’ SWOT analysis: promising pipeline drives stock outlook By Investing.com - Investing.com South Africa
HC Wainwright & Co. Upgrades Arcus Biosciences (RCUS) - Nasdaq
Can Arcus Biosciences Reveal New Cancer Pipeline Updates at March Healthcare Conferences? - StockTitan
Arcus Biosciences' SWOT analysis: promising pipeline drives stock outlook - Investing.com
Arcus Biosciences’ SWOT analysis: promising pipeline drives stock outlook - Investing.com India
Arcus Biosciences gains after H.C. Wainwright upgrades to "buy" - TradingView
HC Wainwright Upgrades Arcus Biosciences to Buy From Neutral, Adjusts Price Target to $24 From $18 - Marketscreener.com
Arcus Biosciences stock rating upgraded to Buy at H.C. Wainwright By Investing.com - Investing.com UK
Arcus Biosciences Reports 2024 Financial Results and Pipeline Progress - TipRanks
Arcus Biosciences reports Q4 EPS ($1.03), consensus ($1.20) - TipRanks
Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Arcus Biosciences earnings beat by $0.20, revenue topped estimates - Investing.com Canada
Arcus Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings Flash (RCUS) Arcus Biosciences Posts Q4 Revenue $36M, vs. FactSet Est of $29.3M - Marketscreener.com
Can Arcus Biosciences' Promising Cancer Drug Results Transform Kidney Cancer Treatment? - StockTitan
Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Kno - GuruFocus.com
Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Inside Arcus Biosciences' Latest Executive Compensation Package: Key Numbers Revealed - StockTitan
The week in pharma: action, reaction and insight – week to February 21 - The Pharma Letter
Arcus Biosciences Inc expected to post a loss of $1.25 a shareEarnings Preview - TradingView
Arcus Biosciences Inc (RCUS) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):